why choose us

First received: May 26, 2023

Clinical Trial: Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Major Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression

Brief Summary: The purpose of the study is to identify brain biomarkers and characteristics that predict individual responses to treatment of major depression with the antidepressant drug sertraline (tradename Zoloft), a common selective serotonin reuptake inhibitor (SSRI) antidepressant.Our central hypothesis is that brain activity and connections jointly measured with functional magnetic resonance imaging (fMRI) and electroencephalogram (EEG) will be able to predict an individual's response to sertraline treatment.

Read more